Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma: Southwest Oncology Group Study S0350.
Mahadevan, Daruka
Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma: Southwest Oncology Group Study S0350. [electronic resource] - Cancer Jan 2013 - 371-9 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1097-0142
10.1002/cncr.27733 doi
ATP Binding Cassette Transporter, Subfamily B, Member 1--metabolism
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Cisplatin--administration & dosage
Deoxycytidine--administration & dosage
Disease-Free Survival
Etoposide--administration & dosage
Female
Humans
Kaplan-Meier Estimate
Lymphoma, T-Cell, Peripheral--drug therapy
Male
Methylprednisolone--administration & dosage
Middle Aged
Neoplasm Staging
Treatment Outcome
Young Adult
Gemcitabine
Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma: Southwest Oncology Group Study S0350. [electronic resource] - Cancer Jan 2013 - 371-9 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1097-0142
10.1002/cncr.27733 doi
ATP Binding Cassette Transporter, Subfamily B, Member 1--metabolism
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Cisplatin--administration & dosage
Deoxycytidine--administration & dosage
Disease-Free Survival
Etoposide--administration & dosage
Female
Humans
Kaplan-Meier Estimate
Lymphoma, T-Cell, Peripheral--drug therapy
Male
Methylprednisolone--administration & dosage
Middle Aged
Neoplasm Staging
Treatment Outcome
Young Adult
Gemcitabine